MCUJF (Medicure) Total Payout Yield % : 0.00 (As of May. 04, 2025)

View and export this data going back to 2004. Start your Free Trial

What is Medicure Total Payout Yield %?

Total Payout Yield % is the percent a company has paid to its shareholders through net repurchases of shares and dividends based on its Market Cap. It is a measure of shareholder return.

Medicure's current Total Payout Yield % is 0.00%.

Medicure Total Payout Yield % Historical Data

The historical data trend for Medicure's Total Payout Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicure Total Payout Yield % Chart

Medicure Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Payout Yield %

Get a 7-Day Free Trial

4.25

Medicure Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Payout Yield %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Medicure's Total Payout Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Medicure's Total Payout Yield %, along with its competitors' market caps and Total Payout Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medicure's Total Payout Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medicure's Total Payout Yield % distribution charts can be found below:

* The bar in red indicates where Medicure's Total Payout Yield % falls into.

Save Embed

;

Save Embed

;

Medicure Total Payout Yield % Calculation

Total Payout Yield % is a measure of shareholder return.

Medicure's Total Payout Yield % for the fiscal year that ended in Dec. 2024 is calculated as

Total Payout Yield %	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Market Cap
	=	- (0	+	0	+	0)	/	6.47032
	=	0.00%

Medicure's annualized Total Payout Yield % for the quarter that ended in Dec. 2024 is calculated as

Total Payout Yield %	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	*	Annualized Factor	/	Market Cap
	=	- (0	+	0	+	0)	*	4	/	6.47032
	=	0.00%

Medicure Total Payout Yield % Explanation

Similar to Dividend Yield, Total Payout Yield % is a measurement of shareholder return. Dividends is not the only way that companies are able to distribute their excess cash back to the shareholders. The other way to distribute the cash is a stock repurchase. The stock repurchase buys back the company's own shares from the marketplace. This results in a reduced number of oustanding shares, making each share worth a greater percentage of the corporation.

Medicure Total Payout Yield % Related Terms

Thank you for viewing the detailed overview of Medicure's Total Payout Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Medicure Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicure Inc (OTCPK:MCUJF) » Definitions » Total Payout Yield %

Comparable Companies

Traded in Other Exchanges

MPH:Canada

Address

2 - 1250 Waverley Street, Winnipeg, MB, CAN, R3T 6C6

Website

https://www.medicure.com

Medicure Inc is a biopharmaceutical company. It is involved in the research, clinical development, and commercialization of human therapeutics for the United States hospital market. Further, it also operates a specialty pharmacy in the United States of America. The company's present focus is the sale and marketing of its cardiovascular products, AGGRASTAT, ZYPITAMAG, and developing its e-commerce and mail order pharmaceutical business. The company operates in two segments namely, Marketing and distribution of commercial products and, Retail and mail order pharmacy. The majority of the company's revenue is generated from the marketing and distribution of the commercial products segment.